Related Experiment Video
Updated: May 9, 2026

Non-invasive Optical Imaging of the Lymphatic Vasculature of a Mouse
Published on: March 8, 2013
High resolution MRI for non-invasive mouse lymph node mapping
Zhuoli Zhang1, Daniel Procissi, Weiguo Li
1Department of Radiology, Northwestern University, United States; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, United States.
Abstract:
Mouse models are fundamental to the study and design of new techniques for the cancer diagnosis and treatment. The lymphatic system plays an active role in oncogenesis and metastatic disease progression. However, the in vivo identification of LNs in mice is challenging with conventional imaging modalities since the LN diameter in normal mice is 1-2 mm. Standard dissection techniques are challenging and can only provide endpoint data. Here, we describe high resolution MRI (HR-MRI) approaches for the non-invasive detection of mouse LNs in vivo. We compare in vivo non-invasive HR-MRI methods (without exogenous contrast injections) to the ex vivo dye injection methods for the identification of commonly studied LNs in both normal mice and a mouse model of pancreatic ductal adenocarcinoma (PDAC). We demonstrated the potential to use HR-MRI techniques as a non-invasive imaging assay for visualizing mouse LNs in vivo.
Insights
High-resolution MRI (HR-MRI) offers a non-invasive method for detecting mouse lymph nodes (LNs) in vivo. This technique overcomes limitations of conventional imaging and dissection for cancer research.
Area of Science:
- Biomedical Imaging
- Oncology Research
- Mouse Models
Background:
- Lymphatic system involvement in cancer progression.
- Challenges in in vivo lymph node identification in mice using conventional methods.
- Limitations of ex vivo dissection techniques for dynamic studies.
Purpose of the Study:
- To develop and evaluate high-resolution MRI (HR-MRI) for non-invasive in vivo detection of mouse lymph nodes.
- To compare HR-MRI with ex vivo dye injection methods for lymph node identification.
- To assess the utility of HR-MRI in both normal mice and a pancreatic ductal adenocarcinoma (PDAC) model.
Main Methods:
- High-resolution magnetic resonance imaging (HR-MRI) without exogenous contrast agents.
- Comparison of in vivo HR-MRI with ex vivo dye tracing techniques.
- Application in normal mice and a genetically engineered mouse model of PDAC.
Main Results:
- Successful non-invasive visualization of mouse lymph nodes in vivo using HR-MRI.
- HR-MRI demonstrated comparable or superior identification of lymph nodes versus ex vivo methods.
- Feasibility of HR-MRI in a preclinical cancer model.
Conclusions:
- HR-MRI is a viable non-invasive imaging assay for visualizing mouse lymph nodes in vivo.
- This technique enhances preclinical cancer research by enabling longitudinal studies of lymphatic involvement.
- HR-MRI offers a significant advancement over traditional methods for mouse lymph node assessment.

